4
Changes in Ownership
MBX Biosciences, Inc. Filed Acc 0001193125-26-035582
President & CEO acquired 35,250 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Hawryluk P. Kent President & CEO | 2026-02-02 | Grant or award | +35,250 | 699,506 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Hawryluk P. Kent President & CEO | 2026-02-02 | Grant or award · Stock option (right to buy) | +164,500 | 164,500 | D: show line 2 in the form |
Loading xslF345X05/ownership.xml…